PATENT CLAIM ANALYSIS

Application Number: 15757166
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["514", "266200"]

Abstract:
The present disclosure provides a method of treating a biliary duct cancer, such as cholangiocarcinoma, by administering a therapeutically effective amount of a compound of formula (I), in particular Varlitinib, an enantiomer thereof or a pharmaceutically acceptable salt of any one of the same.

Claim (Index 7):
A method according to  claim 1 , wherein the compound of formula (I) is Varlitinib: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.275
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15757133', '15757189', '14776552', '12763991', '11100433']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7017629824672378
- 35 USC 102 Novelty (BERT): 0.5474631714315555
- Combined Prediction Score: 0.6863330013636696
- Mean Citation Score: 266.876084
- Max Citation Score: 392.1929
- Similarity Product: 354.28228828390235

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test